WeVote
Log In

Bill

Bill

S 351

STEWARD Act of 2025

119th Congress Introduced by John Boozman and 2 co-sponsors

Bill S 351 creates an interstate compact to award prizes for curing diseases, boosting collaboration and innovation to accelerate medical research and improve patient outcomes.

Held at the desk.
0
WeVote Research Nonpartisan
Bill Summary · S 351

Summary of Bill S 351

Bill Information

  • Bill Number: S 351
  • Title: Adopts the solemn covenant of the states to award prizes for curing diseases interstate compact
  • Status: Referred to Health
  • Introduced: January 08, 2025
  • Classification: Bill

Purpose and Intent

Bill S 351 aims to establish an interstate compact among participating states to incentivize the development of cures for various diseases through a prize system. The primary goal is to accelerate medical research and innovation by offering financial rewards for successful cures, thereby fostering collaboration among states and private entities.

Key Provisions

  • Interstate Compact: The bill proposes the formation of a formal agreement among states to collectively award prizes for breakthroughs in curing diseases.
  • Prize Structure: While specific details on the prize amounts and criteria for awarding them are not outlined in the current version, the bill emphasizes the importance of incentivizing research that leads to effective treatments and cures.
  • Collaboration: The compact encourages collaboration between state governments, research institutions, and private sector stakeholders to maximize resources and expertise in the fight against diseases.

Affected Parties

  • States: Participating states will be involved in the governance and funding of the prize system.
  • Researchers and Innovators: Medical researchers, pharmaceutical companies, and biotech firms stand to benefit from the financial incentives provided by the prize system.
  • Patients: Ultimately, patients suffering from diseases targeted by the compact may gain access to new treatments and cures more rapidly.

Procedural Aspects

  • Referral: The bill was referred to the Health Committee on January 8, 2025, where it will undergo further discussion and potential amendments.
  • Related Legislation: This bill is related to several prior-session bills (S 7770, S 2123, S 2868) and has a companion bill (A 1265) in the Assembly, indicating ongoing legislative interest in this area.

Conclusion

Bill S 351 represents a strategic initiative to enhance disease research and treatment through a collaborative prize system among states. By incentivizing innovation, the bill seeks to address critical health challenges and improve patient outcomes across the nation. Further discussions in the Health Committee will clarify the implementation details and financial commitments required from participating states.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.